Tue, December 16, 2008
Mon, December 15, 2008
Sun, December 14, 2008
Fri, December 12, 2008
Thu, December 11, 2008
Wed, December 10, 2008
Tue, December 9, 2008
Mon, December 8, 2008
Sun, December 7, 2008
Sat, December 6, 2008
Fri, December 5, 2008
Thu, December 4, 2008
Wed, December 3, 2008
[ Wed, Dec 03rd 2008 ]: Market Wire
Protherics PLC: Offer Update
Tue, December 2, 2008
Mon, December 1, 2008
Sun, November 30, 2008
Fri, November 28, 2008
Thu, November 27, 2008
Wed, November 26, 2008
Tue, November 25, 2008
Mon, November 24, 2008
Thu, November 20, 2008
Wed, November 19, 2008
Tue, November 18, 2008
Mon, November 17, 2008

Biodel to Report Fourth Quarter and Fiscal Year 2008 Financial Results on December 10, 2008


  Copy link into your clipboard //health-fitness.news-articles.net/content/2008/ .. -2008-financial-results-on-december-10-2008.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

DANBURY, Conn.--([ BUSINESS WIRE ])--Biodel Inc. (Nasdaq: BIOD) will issue its fourth quarter and fiscal year 2008 financial results on December 10, 2008. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.

December 10, 2008 schedule:

          7:00 am EST:       Q4 and fiscal year 2008 results will be
distributed by Business Wire
7:50 am EST: Conference call participants should dial:
+1 877-852-6575 (United States) or
+1 719-325-4815 (International)
8:00 am EST: Conference call begins

Interested parties may access a live audio webcast of the conference call in the investor section of Biodel's website at [ http://www.biodel.com ]. The audio webcast will be archived and available for replay through the website.

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for endocrine disorders, such as diabetes and osteoporosis. Biodel's product candidates are developed using VIAdelTM technology, which reformulates existing FDA-approved peptide drugs. For further information regarding Biodel, please visit the company's website at [ www.Biodel.com ].

BIOD-G


Publication Contributing Sources

Similar Health and Fitness Publications